Connect with us

National

Jimmy Carter, beloved humanitarian and human rights advocate, was supporter of LGBTQ rights

Historic, first-ever meeting with gay activists held at Carter White House in 1977

Published

on

President Jimmy Carter (Photo by kathclick/Bigstock)

Former President Jimmy Carter, who died Sunday at the age of 100, is being remembered by both admirers and political observers as a progressive southern Democrat and former Georgia governor who pushed for an end to racial injustice in the U.S., and as a beloved humanitarian who worked hard as president and during his post-presidential years to improve the lives of people in need throughout the world.

Carter’s death comes over a year after the passing on Nov. 19, 2023, of former First Lady Rosalynn Carter, his wife and devoted partner of 77 years. Carter also had the distinction of becoming the oldest living former U.S. president after the death at the age of 94 of former President George H.W. Bush on Nov. 30, 2018.

The former president’s passing also follows his decision in February 2023 to receive hospice care at his family home in Plains, Ga., at the age of 98 after declining additional medical intervention to continue treatment of several ailments that required hospitalization over the previous several months.

Modest beginnings

Jimmy Carter was born Oct. 1, 1924, at a hospital in his hometown of Plains, Ga., where he was raised on his parents’ peanut farm. His decades of public service took place after he graduated from the United States Naval Academy in 1946 and he began his service as a submariner.

He left the Navy after the death of his father in 1953, taking over the Carter family business in what was then a segregated Georgia with strong lines between Blacks and Whites. He was an early supporter of the nascent civil rights movement and became an activist within the Democratic Party and a leading voice for the change needed to end racial segregation.

Carter was first elected to public office in 1963 as a state senator, for which he served until 1967. He successfully ran for governor in 1970 and served as Georgia governor until 1975, when he turned his attention to a possible run for U.S. president as a progressive southern Democrat.

Many political observers have said although he was relatively unknown outside of Georgia and within the leadership of the Democratic Party, Carter was able to parlay voter fatigue and the public’s response to the Nixon Watergate scandal and the growing opposition to the Vietnam War to establish himself as an outsider candidate removed from scandal and bad policies.

Appearing to answer the nation’s needs at that time, Carter’s slogan at the start of his presidential campaign was, “A Leader, For A Change.” He came out ahead of nine other Democrats, most of them better known than him, to win the 1976 Democratic nomination for president.

The thirty-ninth President of the United States, Carter served from 1977 to 1981 at a time when support for LGBTQ people was in its early stages, with many elected officials remaining cautious about the potential political risk for outwardly embracing “gay rights.”

Yet during his 1976 presidential campaign, Carter surprised some political observers when he stated at a press conference during a campaign trip to San Francisco in May of that year that he would sign the Equality Act, the gay civil rights bill introduced by then U.S. Rep. Bella Abzug (D-N.Y.) if it reached his desk as president.

“I will certainly sign it, because I don’t think it’s right to single out homosexuals for abuse or special harassment,” he said.

While Carter did not back away from that statement, gay activists were disappointed at the time of the Democratic National Convention in New York City in July 1976, when they said convention officials at the request of the Carter campaign refused to include a gay rights plank as part of the Democratic Party’s platform approved at the convention.

Some LGBT Democratic activists attending the convention said they agreed with the contention of Carter supporters that Carter should not be hampered by a controversial issue that could hurt his chances of defeating Republican President Gerald Ford in the November 1976 presidential election.  

Carter narrowly defeated Ford in the election. Some political observers said Ford might have won except for the negative fallout from his decision to pardon former President Richard Nixon, who resigned from office in the midst of the Watergate scandal and allegations that Nixon engaged in illegal activity by playing some role in the break-in at the Democratic Party headquarters in D.C.’s Watergate office building that triggered the scandal.

In March of 1977, just over two months after Carter was inaugurated as president, the White House hosted an historic, first-of-its-kind meeting with fourteen prominent gay rights leaders from throughout the country. Carter did not attend the meeting and was staying at the presidential retreat at Camp David, Md., at the time of the meeting, which was organized by presidential assistant for public liaison Margaret “Midge” Costanza. But White House officials said Carter was aware of the meeting and supported efforts by Costanza and other White House staffers to interact with the gay leaders.

“The meeting was a happy milestone on the road to full equality under the law for gay women and men, and we are highly optimistic that it will soon lead to complete fulfilment of President Carter’s pledge to end all forms of Federal discrimination on the basis of sexual orientation,” said Jean O’Leary, then co-executive director of the National Gay Task Force, which helped select the gay activists who attended the meeting. Among those attending was D.C. pioneer gay rights advocate Frank Kameny.

But about one year later in 1978, some LGBT leaders joined famed gay San Francisco Supervisor Harvey Milk in criticizing Carter for being slow to speak out against California’s Proposition 6, also known as the Briggs Initiative, a ballot measure asking voters to approve a law to ban gay and lesbian individuals from working in California public schools as teachers or staff members. 

In a June 28, 1978, letter to Carter, Milk called on the president to take a stand against Proposition 6 and speak out more forcefully in support of LGBT rights. “As the President of a nation which includes 15-20 million lesbians and gay men, your leadership is vital and necessary,” Milk wrote.

About four months later,  in a Nov. 4, 1978, campaign speech in support of California Democratic candidates in Sacramento, three days before the Nov. 7 election, Carter spoke out against Proposition 6 and urged voters to defeat it. Others who spoke out against it earlier were former President Ford and then former California GOP Governor Ronald Reagan as well as California’s then Democratic Governor Edmund Jerry Brown.

Voters defeated the proposition by a margin of 58.4 percent to 41.5 percent, with opponents of the anti-gay measure thanking Carter for speaking out against it.

During his presidency Carter helped put in place two new federal cabinet-level agencies – the Department of Energy and the Department of Education. One of the highlights of his presidential years was his role in bringing about the historic Camp David Accords, the peace agreements between Israeli Prime Minister Menachem Begin and Egyptian President Anwar Sadat.

The initial agreement, signed in September 1978, which led to the first-ever peace treaty between Israel and Egypt one year later in 1979, came about after Carter invited the two Middle East leaders to meet together with him and to begin negotiations at the U.S. presidential retreat at Camp David, Md. Sadat and Begin were awarded the Nobel Peace Prize in 1978 for their contributions to the historic agreements that were brokered by President Carter.

Despite this and other important achievements, Carter faced multiple setbacks the following year in 1979 related to international developments that political observers say Carter and his advisors failed to address properly. Among them was the revolution in Iran that toppled the reign of Shah Mohammad Reza Pahlavi and installed the fundamentalist Islamic regime headed by Ayatollah Khomeini that led to a dramatic drop in Iran’s production and sale of oil. That quickly led to a dramatic rise in the cost of  gasoline for American consumers along with a shortage of gas at fuel pumps leading to long lines as filling stations.

If that were not enough, Carter was hit with the take-over of the U.S. Embassy in Tehran on Nov. 4, 1979, by militant Iranian youths supported and encouraged by Khomeini who held as hostages 52 U.S. diplomats and American citizens with no sign that they would be released any time soon. As Carter’s poll ratings declined, then U.S. Senator Edward Kennedy (D-Mass.) announced his candidacy for the 1980 Democratic presidential nomination in a rare challenge to an incumbent president.

With all that as a backdrop, gay Democratic activists launched a campaign to elect far more openly gay and lesbian delegates to the 1980 Democratic National Convention than they had in 1976. A record number of just over 100 gay and lesbian delegates emerged from this effort, with many of them pledged to Kennedy. And this time around, the Democratic Party leaders backing Carter at the convention, as well as Carter himself, according to some reports,  expressed support for including a “gay” plank in the party’s platform, which the convention adopted in an historic first.

But when it became clear that Kennedy and California Governor Jerry Brown, who also challenged Carter for the 1980 Democratic nomination, did not have enough delegates to wrest the nomination from Carter, gay activists expressed concern that the Carter campaign was backing away from taking a stronger position in support of gay rights.

Their main concern was that the response by the Carter campaign to a “gay” questionnaire the National Gay Task Force sent to all the Democratic and Republican presidential candidates seeking their party’s nomination in 1980 was significantly less specific than the response by Kennedy and Brown.

Among other things, the activists said the Carter campaign’s response, which was prepared by Carter Campaign Chairperson Robert Strauss, did not make a commitment for Carter to sign an executive order ending the longstanding discrimination against gays and lesbians in federal government agencies, including the military.  The Carter campaign response also did not express support for the national gay rights bill, even though Carter had expressed support for it back in 1976.

Carter supporters, including many in the then gay and lesbian community, pointed out that Straus’s response to the questionnaire expressed overall support for the rights of the gay and lesbian community and a commitment to follow up on that support over the next four years.  Gay Carter supporters also pointed out that Carter would be far more supportive than Ronald Regan, who had captured the 1980 Republican presidential nomination.

Some historians have said that the final straw in dooming Carter’s chances for a second term, in addition to his seeming inability to gain the release of the American hostages held in Iran, was the final televised debate between Carter and Reagan. With most political observers saying Reagan was an infinitely superior television candidate, those observations appeared to be confirmed when Carter’s poll numbers dropped significantly following the final debate.

Although Reagan captured 51.8 percent of the popular vote, with Carter receiving 41.0 percent and independent candidate John Anderson receiving 6.6 percent, Reagan won an Electoral College landslide, with 489 electoral votes compared to 49 for Carter. Reagon won in 44 states, with Carter winning in just 6 states and the District of Columbia.

Carter Center and post-presidential career

Both Carter supporters as well as critics and independent political observers agree that Jimmy Carter’s years after leaving the White House have been filled with years of work dedicated to his passion for the advancement of human rights, peace negotiations, advancing worldwide democracy, and advancing disease prevention and eradication in developing nations.

Most of that work was accomplished through The Carter Center, an Atlanta based nonprofit organization that Carter and wife Rosalynn founded in 1982. Twenty years after its founding, Jimmy Carter was awarded the Nobel Peace Prize in 2002. The Nobel Committee, among other things, stated it selected Carter for the Nobel Peace Prize “for his decades of untiring effort to find peaceful solutions to international conflicts, to advance democracy and human rights, and to promote economic and social development.”

In the years following his presidency Carter also continued to lend support as an ally to the LGBTQ community. During a book tour promoting his book, “A Full Life: Reflections at Ninety,” Carter stated in a July 2018 interview with Huff Post Live, that he supported same-sex marriage.

As a long-time self-described born-again Christian, Carter said in the interview, “I think Jesus would approve gay marriage,” adding, “I  think Jesus would encourage any love affair if it was honest and sincere and was not damaging to anyone else, and I don’t see that gay marriage damages anyone else.”

His expression of support for same-sex marriage came four years after he responded to a question about his thoughts about LGBTQ rights and religion during an appearance at Michigan’s Grand Rapids Community College in 2014.

“I never knew of any word or action of Jesus Christ that discriminated against anyone,” he said. “Discrimination against anyone and depriving them of actual equal rights in the United States is a violation of the basic principles of the Constitution that all of us revere in this country,” Carter stated at the event.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Federal Government

Holiday week brings setbacks for Trump-Vance trans agenda

Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.

Published

on

While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.

19 states sue RFK Jr. to end gender-affirming care ban

New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.

In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.

“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”

The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.

The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.

The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.

“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”

The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.

At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”

DOJ stopped from gaining health care records of trans youth

U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”

Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.

“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”

Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.

In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.

“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.

The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”

Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.

Continue Reading

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

Popular